Rwanda, Tanzania, Ethiopia and Kenya have launched a programme to monitor drugs released into the market. Under a project, dubbed “Pharmacovigilance Infrastructure and Post-Marketing Surveillance System Capacity building for Regional Medicine Regulatory Harmonisation,” participating countries will train pharmacists and other medical personnel on safety, particularly the collection, analysis, monitoring and prevention of adverse effects of drugs and therapies.
A consortium that has been formed will build partnerships between local academic institutions and national medicine regulatory authorities as it seeks to strengthen the region’s drug safety and post-marketing surveillance system for medicines.
